THOMAS H CABELL
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SMYRNA, TN NPI 1932274503
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease TN BOSTON SCIENTIFIC CORPORATION All categories
General Payments — all program years on this page
$13,135.24
- Category: General Payments
- Program years: PY2018–2024
- Record count: 720
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $863.91 across 41 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $863.91 | 41 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $165.61 | 8 |
| Amgen Inc. | $91.69 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.44 | 4 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $67.49 | 3 |
| Kiniksa Pharmaceuticals International, plc | $61.61 | 3 |
| PFIZER INC. | $60.70 | 3 |
| Janssen Pharmaceuticals, Inc | $59.15 | 3 |
| SCPHARMACEUTICALS INC. | $45.17 | 2 |
| TACTILE SYSTEMS TECHNOLOGY INC | $44.70 | 2 |
| Novo Nordisk AS | $44.59 | 2 |
| Acerta Pharma LLC | $34.33 | 2 |
| Abbott Laboratories | $32.54 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.08 | 1 |
| Alnylam Pharmaceuticals Inc. | $23.67 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.14 | 1 |
By program year
Records — PY2024 (41)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.